JP2013521762A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521762A5
JP2013521762A5 JP2012542287A JP2012542287A JP2013521762A5 JP 2013521762 A5 JP2013521762 A5 JP 2013521762A5 JP 2012542287 A JP2012542287 A JP 2012542287A JP 2012542287 A JP2012542287 A JP 2012542287A JP 2013521762 A5 JP2013521762 A5 JP 2013521762A5
Authority
JP
Japan
Prior art keywords
cells
mesoderm
culture
hematopoietic
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012542287A
Other languages
English (en)
Other versions
JP2013521762A (ja
JP5777115B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/057503 external-priority patent/WO2011115308A1/en
Publication of JP2013521762A publication Critical patent/JP2013521762A/ja
Publication of JP2013521762A5 publication Critical patent/JP2013521762A5/ja
Application granted granted Critical
Publication of JP5777115B2 publication Critical patent/JP5777115B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (10)

  1. 以下の培養工程により、多能性幹細胞を異種細胞と共培養することなく培養して中胚葉細胞を得ることを特徴とする、中胚葉細胞の製造方法
    (1)BMP4を含み、Wnt3aを含まない無血清培地で多能性幹細胞を接着培養する工程、
    (2)工程(1)で得られた細胞をBMP4およびWnt3aを含む無血清培地で接着培養する工程、および
    (3)工程(2)で得られた細胞をVEGFおよびWnt3aを含む無血清培地で接着培養する工程。
  2. 前記接着培養は、Matrigel(商標)でコートされた培養器で行われる、請求項に記載の方法。
  3. 前記工程(1)が1日間行われる、請求項1または2に記載の方法。
  4. 前記工程(2)が3日間行われる、請求項1から3のいずれか1項に記載の方法。
  5. 前記工程(3)が2日間行われる、請求項1から4のいずれか1項に記載の方法。
  6. 前記中胚葉細胞が、KDR陽性およびCD34陽性細胞を含む、請求項1から5のいずれか1項に記載の方法。
  7. a) 請求項1から6のいずれか1項に記載の方法で中胚葉細胞を製造する工程、および
    b) a)の中胚葉細胞から造血幹細胞、造血前駆細胞、骨髄系細胞、巨核球、赤血球および/または好中球を製造する工程を含む、造血幹細胞、造血前駆細胞、骨髄系細胞、巨核球、赤血球および/または好中球の製造方法。
  8. 前記工程b)は工程a)で得られた中胚葉細胞を造血因子の存在下で培養することによって行われる、請求項に記載の方法。
  9. 前記造血因子が、SCF、TPO、EPO、IL-3、 Flt3-ligand、FP-6およびG-CSFからなる群より選ばれる、請求項に記載の方法。
  10. 前記工程(b)が9日以上の間行われる、請求項7から9のいずれか1項に記載の方法。
JP2012542287A 2010-03-18 2011-03-18 多能性幹細胞から中胚葉細胞への分化誘導法 Expired - Fee Related JP5777115B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31517010P 2010-03-18 2010-03-18
US61/315,170 2010-03-18
PCT/JP2011/057503 WO2011115308A1 (en) 2010-03-18 2011-03-18 Method for inducing differentiation of pluripotent stem cells into mesodermal cells

Publications (3)

Publication Number Publication Date
JP2013521762A JP2013521762A (ja) 2013-06-13
JP2013521762A5 true JP2013521762A5 (ja) 2014-06-19
JP5777115B2 JP5777115B2 (ja) 2015-09-09

Family

ID=44649386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012542287A Expired - Fee Related JP5777115B2 (ja) 2010-03-18 2011-03-18 多能性幹細胞から中胚葉細胞への分化誘導法

Country Status (4)

Country Link
US (1) US8652845B2 (ja)
EP (1) EP2547764B1 (ja)
JP (1) JP5777115B2 (ja)
WO (1) WO2011115308A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9074186B2 (en) 2012-08-15 2015-07-07 Boston Medical Center Corporation Production of red blood cells and platelets from stem cells
CN105101979B (zh) * 2012-12-21 2021-10-08 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
US10240126B2 (en) 2013-06-12 2019-03-26 Kyoto University Induced pluripotent stem cell selection method and method for inducing differentiation to blood cells
FR3024462A1 (fr) * 2014-07-29 2016-02-05 Univ Pierre Et Marie Curie Paris 6 Procede de production in vitro de progeniteurs adipocytaires et d'adipocytes
WO2016085765A1 (en) 2014-11-25 2016-06-02 President And Fellows Of Harvard College Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
WO2016123100A1 (en) * 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US10669529B2 (en) 2015-07-17 2020-06-02 Kyoto University Method for inducing vascular endothelial cells
JP6646311B2 (ja) * 2015-07-17 2020-02-14 国立大学法人京都大学 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
AU2016349504B2 (en) 2015-11-04 2023-02-09 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells
AU2016348342B2 (en) * 2015-11-04 2023-07-06 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
JP7000311B2 (ja) * 2016-03-23 2022-02-04 国立大学法人京都大学 血球分化能の高い中胚葉誘導方法
US11559548B2 (en) 2017-03-14 2023-01-24 Kyoto University Method for producing helper T cells from pluripotent stem cells
CN113207297B (zh) * 2018-12-20 2024-09-24 住友化学株式会社 包含胚胎型成红细胞的细胞群体及其制备方法、细胞培养组合物以及化合物试验方法
GB201911957D0 (en) * 2019-08-20 2019-10-02 Adaptimmune Ltd Methods of producing haemogenic progenitor cells from pluripotent stem cells
WO2021107117A1 (ja) * 2019-11-28 2021-06-03 国立大学法人京都大学 多能性幹細胞からの造血細胞の製造法
JP7072756B2 (ja) * 2019-12-27 2022-05-23 国立大学法人京都大学 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
AU2021226507A1 (en) * 2020-02-28 2022-09-01 Purdue Research Foundation Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition
JP7409203B2 (ja) 2020-04-02 2024-01-09 Toppanホールディングス株式会社 紙箱
WO2022113056A1 (en) 2020-11-30 2022-06-02 Crispr Therapeutics Ag Gene-edited natural killer cells
CN112574944A (zh) * 2020-12-14 2021-03-30 广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) 基于体外诱导eps发育形成类囊胚结构的方法
US11473060B2 (en) 2020-12-30 2022-10-18 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into NK cells
GB202102297D0 (en) * 2021-02-18 2021-04-07 Adaptimmune Ltd Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
CN113249303B (zh) * 2021-05-07 2022-07-29 华中农业大学 血管内皮细胞生长因子在促进鸡原始生殖细胞增殖和迁移中的应用
CN114457006B (zh) * 2022-02-21 2023-07-28 广州华越肾科再生医学科技有限公司 一种通过不连续分化制备肾脏足细胞的方法
CN115247152B (zh) * 2022-09-21 2022-12-27 呈诺再生医学科技(北京)有限公司 制备造血干细胞或造血干祖细胞的方法及培养长期再生造血干细胞的方法
WO2024182609A1 (en) * 2023-03-02 2024-09-06 R.P. Scherer Technologies, Llc Methods of differentiation of pluripotent stem cells into mesenchymal stromal cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
AU2002360424A1 (en) * 2001-11-26 2003-06-10 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
US7452718B2 (en) * 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
WO2007120811A2 (en) * 2006-04-14 2007-10-25 Advanced Cell Technology, Inc. Hemangio-colony forming cells
WO2008056779A1 (fr) 2006-11-09 2008-05-15 Japan As Represented By The President Of International Medical Center Of Japan Procédé destiné à la culture et au passage d'une cellule souche embryonnaire de primate, et procédé destiné à induire la différenciation de la cellule souche embryonnaire
SG188918A1 (ja) * 2008-03-17 2013-04-30 Agency Science Tech & Res
CN109988749B (zh) * 2008-03-27 2023-06-16 阿斯特利亚斯生物治疗股份公司 使灵长类多能干细胞分化成为造血谱系细胞
WO2010008100A1 (ja) 2008-07-17 2010-01-21 国立大学法人名古屋大学 骨格筋細胞又は骨細胞の誘導法

Similar Documents

Publication Publication Date Title
JP2013521762A5 (ja)
KR102151210B1 (ko) 규정된 조건하에서 인간 만능성 줄기 세포의 조혈내피세포 분화를 위한 방법 및 재료
Vodyanik et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells
JP5777115B2 (ja) 多能性幹細胞から中胚葉細胞への分化誘導法
AU2011227274B2 (en) Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
Chen et al. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells
Feng et al. Scalable generation of universal platelets from human induced pluripotent stem cells
Pearson et al. In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation
Xu et al. Strategies for derivation of endothelial lineages from human stem cells
Kumar et al. Understanding the journey of human hematopoietic stem cell development
Chang et al. Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview
WO2011114237A3 (en) Composition and method for enabling proliferation of pluripotent human stem cells
WO2015199127A1 (ja) 中胚葉細胞および造血細胞の製造方法
JP6646311B2 (ja) 多能性幹細胞から中胚葉前駆細胞および血液血管前駆細胞への分化誘導法
Jackson et al. Enforced expression of HOXB4 in human embryonic stem cells enhances the production of hematopoietic progenitors but has no effect on the maturation of red blood cells
Gao et al. Differentiation and application of human pluripotent stem cells derived cardiovascular cells for treatment of heart diseases: Promises and challenges
Anstee Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS)
Subramanian et al. Scalable expansion of multipotent adult progenitor cells as three‐dimensional cell aggregates
WO2013141731A8 (en) Process for ex-vivo expansion of hematopoietic stem cells in a bioreactor
Philonenko et al. Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
JP6420933B2 (ja) 内皮細胞の製造方法
JP2013226127A5 (ja)
Saeki et al. Highly efficient and feeder‐free production of subculturable vascular endothelial cells from primate embryonic stem cells
Hassan et al. Blood Pharming: Exploring the Progress and Hurdles in Producing in-vitro Red Blood Cells for Therapeutic Applications
Jiang et al. Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges